HLA class II genes determine the natural variance of hepatitis C viral load

被引:43
作者
Fanning, LJ
Levis, J
Kenny-Walsh, E
Whelton, M
O'Sullivan, K
Shanahan, F
机构
[1] Natl Univ Ireland Univ Coll Cork, Dept Med, Hepatitis Unit C, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland
关键词
D O I
10.1053/jhep.2001.20642
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to investigate the relationship between human leukocyte antigen (HLA) class II genes and the natural fluctuations in hepatitis C viral load in a homogeneous patient population. The study group consisted of 57 viremic (hepatitis C virus [HCV] 1b) women for whom HLA class II DRB1 and DQB1 haplotyping, virologic, histologic, and biochemical markers of disease activity were available. All patients were infected with HCV 1b from the same source of hepatitis C-contaminated anti-D immunoglobulin during the period from May 1977 to November 1978, The mean slope of change of viral load was 0.34 (SD +/- 0.73) log(10) viral copies/mL/year, which is significantly different from zero, P < 10(-9). Analysis of the relationship between the slope of change of viral load and HLA class II haplotype indicated a significantly different slope of change of viral load between the alleles of (1) DRB1"15 and DRB1*0701, and (2) DQB1*0602 and DQB1*0201, P-c = .036 and P-c = .026 after Bonferroni correction for multiple comparisons, respectively. Significant differences for grade and stage of disease at liver biopsy were observed for DQB1*0501 and DQB1*0201 alleles; P = .019, r(s) = .64, and P = .047, r(s) = .57, respectively. In addition, significant differences in stage of disease were found to exist between DRB1*13 and DRB1*0701, P = .031, r(s) = -.71. Our results define an association between the slope of change of viral load and HLA class II haplotype in patients infected with genotype Ib of HCV, This suggests a role for host immunogenetic factors in HCV infection in this homogeneous group.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 63 条
[1]   Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection [J].
Alric, L ;
Fort, M ;
Izopet, J ;
Vinel, JP ;
Charlet, JP ;
Selves, J ;
Puel, J ;
Pascal, JP ;
Duffaut, M ;
Abbal, M .
GASTROENTEROLOGY, 1997, 113 (05) :1675-1681
[2]   THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES [J].
ALTER, MJ ;
MARGOLIS, HS ;
KRAWCZYNSKI, K ;
JUDSON, FN ;
MARES, A ;
ALEXANDER, WJ ;
HU, PY ;
MILLER, JK ;
GERBER, MA ;
SAMPLINER, RE ;
MEEKS, EL ;
BEACH, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) :1899-1905
[3]   Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease [J].
Asti, M ;
Martinetti, M ;
Zavaglia, C ;
Cuccia, MC ;
Gusberti, L ;
Tinelli, C ;
Cividini, A ;
Bruno, S ;
Salvaneschi, L ;
Ideo, G ;
Mondelli, MU ;
Silini, EM .
HEPATOLOGY, 1999, 29 (04) :1272-1279
[4]   Association of the HLA-DRB1*01 allele with spontaneous viral clearance in an Irish cohort infected with hepatitis C virus via contaminated anti-D immunoglobulin [J].
Barrett, S ;
Ryan, E ;
Crowe, J .
JOURNAL OF HEPATOLOGY, 1999, 30 (06) :979-983
[5]   Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation [J].
Belli, LS ;
Zavaglia, C ;
Alberti, AB ;
Poli, F ;
Rondinara, G ;
Silini, E ;
Taioli, E ;
de Carlis, L ;
Scalamogna, M ;
Forti, D ;
Pinzello, G ;
Idèo, G .
HEPATOLOGY, 2000, 31 (06) :1345-1350
[6]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[7]   Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia [J].
Cramp, ME ;
Carucci, P ;
Underhill, J ;
Naoumov, NV ;
Williams, R ;
Donaldson, PT .
JOURNAL OF HEPATOLOGY, 1998, 29 (02) :207-213
[8]   HIV increases hepatitis C viraemia irrespective of the hepatitis C virus genotype [J].
Cribier, B ;
Schmitt, C ;
Rey, D ;
Uhl, G ;
Lang, JM ;
Vetter, D ;
Kirn, A ;
StollKeller, F .
RESEARCH IN VIROLOGY, 1997, 148 (04) :267-271
[9]   HIGH HEPATITIS-C VIREMIA AND IMPAIRED ANTIBODY-RESPONSE IN PATIENTS COINFECTED WITH HIV [J].
CRIBIER, B ;
REY, D ;
SCHMITT, C ;
LANG, JM ;
KIRN, A ;
STOLLKELLER, F .
AIDS, 1995, 9 (10) :1131-1136
[10]   Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C [J].
Davis, GL ;
Esteban-Mur, R ;
Rustgi, V ;
Hoefs, J ;
Gordon, SC ;
Trepo, C ;
Shiffman, ML ;
Zeuzem, S ;
Craxi, A ;
Ling, MH ;
Albrecht, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (21) :1493-1499